In addition, genetic mutations, such as changes in the breast cancer gene 2 (BRCA2), checkpoint kinase 2 (CHEK2), ataxia telangiectasia mutated (ATM), and the breast cancer gene 1 (BRCA1) are present in diagnosed patients with PCa [4]. The gene discussed is CHEK2; the disease is posterior cortical atrophy.